• Establishment Labs Holdings Inc ESTA.OQ reported a quarterly adjusted loss of $1.19​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -79 cents. The mean expectation of seven analysts for the quarter was for a loss of 67 cents per share. Wall Street expected results to range from -75 cents to -44 cents per share.

• Revenue rose 41% to $44.51 million from a year ago; analysts expected $44.61 million.

• Establishment Labs Holdings Inc's reported EPS for the quarter was a loss of $1.19​.

• The company reported a quarterly loss of $34.53 million.

• Establishment Labs Holdings Inc shares had fallen by 22.3% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 0.5% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Establishment Labs Holdings Inc is $61.00

This summary was machine generated from LSEG data February 26 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)